Tail Flick Modification of Orexin-a Induced Changes of Electrophysiological Parameters in the Rostral Ventromedial Medulla

Overview

Journal Cell J

Specialty Cell Biology

Date 2014 Feb 26

PMID 24567942

Citations 5

Authors

Hassan Azhdari-Zarmehri

Saeed Semnanian

Yaghoub Fathollahi

Firouz Ghaderi Pakdel

Affiliations

Soon will be listed here.

Abstract

Objective: It is well known that intracerebroventricular (ICV) and supraspinal injections of orexin-A elicit analgesia, but the mechanism(s) of action remains unidentified. This study aims to characterize the effect of orexin-A on rostral ventromedial medulla (RVM) neurons which are involved in the descending nociception modulating pathway.

Materials And Methods: In this experimental study, we injected orexin-A or vehicle di- rectly into rats' ICV while the tail flick (TF) latencies were measured and the on- and off-cell firing activities were monitored for more than 60 minutes.

Results: In response to noxious stimuli on the tail, we observed increased firing rate of on-cells and a decreased association with the firing rate of off-cells and in neutral cells the firing rate was unchanged just prior to tail flicking. ICV injection of orexin-A decreased the spontaneous firing rate of on-cells (the type of RVM neurons believed to have facilitatory action on nociception). Furthermore, orexin-A increased firing rate of off-cells (the type of RVM neurons believed to have an inhibitory action on nocicep- tion). Orexin-A reduced the TF-related responses of on-cells and TF-related pause duration of off-cells.

Conclusion: These results have shown that the analgesic effect produced by orexin-A may be induced by brainstem neurons. It is suggested that the orexinergic system from the hypothalamus to the RVM may have a potential role in modulation of nociceptive transmission.

Citing Articles

The ability of orexin-A to modify pain-induced cyclooxygenase-2 and brain-derived neurotrophic factor expression is associated with its ability to inhibit capsaicin-induced pulpal nociception in rats.

Shahsavari F, Abbasnejad M, Esmaeili-Mahani S, Raoof M Korean J Pain. 2022; 35(3):261-270.

PMID: 35768981 PMC: 9251390. DOI: 10.3344/kjp.2022.35.3.261.

The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation.

Fakhoury M, Salman I, Najjar W, Merhej G, Lawand N Front Neurosci. 2020; 14:101.

PMID: 32116534 PMC: 7029733. DOI: 10.3389/fnins.2020.00101.

Administration of orexin receptor 1 antagonist into the rostral ventromedial medulla increased swim stress-induced antinociception in rat.

Soliemani N, Moslem A, Shamsizadeh A, Azhdari-Zarmehri H Iran J Basic Med Sci. 2016; 19(5):542-9.

PMID: 27403261 PMC: 4923475.

Orexin-a modulates firing of rat rostral ventromedial medulla neurons: an in vitro study.

Azhdari-Zarmehri H, Semnanian S, Fathollahi Y Cell J. 2015; 17(1):163-70.

PMID: 25870847 PMC: 4393666. DOI: 10.22074/cellj.2015.524.

Permanent lesion in rostral ventromedial medulla potentiates swim stress-induced analgesia in formalin test.

Shamsizadeh A, Soliemani N, Mohammad-Zadeh M, Azhdari-Zarmehri H Iran J Basic Med Sci. 2014; 17(3):209-15.

PMID: 24847424 PMC: 4016692.

References

Harris G, Wimmer M, Aston-Jones G . A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005; 437(7058):556-9. DOI: 10.1038/nature04071. View

Cheng J, Chou R, Hwang L, Chiou L . Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther. 2003; 307(3):1065-71. DOI: 10.1124/jpet.103.056663. View

Heinricher M, McGaraughty S, Grandy D . Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol. 1998; 78(6):3351-8. DOI: 10.1152/jn.1997.78.6.3351. View

Burlet S, Tyler C, Leonard C . Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci. 2002; 22(7):2862-72. PMC: 6758338. DOI: 20026234. View

Behbehani M, Park M, Clement M . Interactions between the lateral hypothalamus and the periaqueductal gray. J Neurosci. 1988; 8(8):2780-7. PMC: 6569401. View

de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View

Erami E, Azhdari-Zarmehri H, Rahmani A, Ghasemi-Dashkhasan E, Semnanian S, Haghparast A . Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats. Pharmacol Biochem Behav. 2012; 103(2):212-9. DOI: 10.1016/j.pbb.2012.08.010. View

Marcus J, Aschkenasi C, Lee C, Chemelli R, Saper C, Yanagisawa M . Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001; 435(1):6-25. DOI: 10.1002/cne.1190. View

Yamamoto T, Saito O, Shono K, Hirasawa S . Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur J Pharmacol. 2003; 481(2-3):175-80. DOI: 10.1016/j.ejphar.2003.09.022. View

10.

Heinricher M, McGaraughty S, Tortorici V . Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol. 2001; 85(1):280-6. DOI: 10.1152/jn.2001.85.1.280. View

11.

Lu X, Bagnol D, Burke S, Akil H, Watson S . Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav. 2000; 37(4):335-44. DOI: 10.1006/hbeh.2000.1584. View

12.

Trivedi P, Yu H, MacNeil D, Van der Ploeg L, Guan X . Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998; 438(1-2):71-5. DOI: 10.1016/s0014-5793(98)01266-6. View

13.

Heidari-Oranjaghi N, Azhdari-Zarmehri H, Erami E, Haghparast A . Antagonism of orexin-1 receptors attenuates swim- and restraint stress-induced antinociceptive behaviors in formalin test. Pharmacol Biochem Behav. 2012; 103(2):299-307. DOI: 10.1016/j.pbb.2012.08.007. View

14.

Izadi Mobarakeh J, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M . Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides. 2005; 26(5):767-77. DOI: 10.1016/j.peptides.2005.01.001. View

15.

Suyama H, Kawamoto M, Shiraishi S, Gaus S, Kajiyama S, Yuge O . Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats. In Vivo. 2004; 18(2):119-23. View

16.

Jones B . From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005; 26(11):578-86. DOI: 10.1016/j.tips.2005.09.009. View

17.

Zarmehri H, Semnanian S, Fathollahi Y, Erami E, Khakpay R, Azizi H . Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats. J Pain. 2010; 12(2):280-7. DOI: 10.1016/j.jpain.2010.09.006. View

18.

Erami E, Azhdari-Zarmehri H, Ghasemi-Dashkhasan E, Esmaeili M, Semnanian S . Intra-paragigantocellularis lateralis injection of orexin-A has an antinociceptive effect on hot plate and formalin tests in rat. Brain Res. 2012; 1478:16-23. DOI: 10.1016/j.brainres.2012.08.013. View

19.

Liu R, van den Pol A, Aghajanian G . Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci. 2002; 22(21):9453-64. PMC: 6758063. View

20.

Korotkova T, Eriksson K, Haas H, Brown R . Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept. 2002; 104(1-3):83-9. DOI: 10.1016/s0167-0115(01)00323-8. View